← Back to Search

Behavioral Intervention

FitBit for Multiple Myeloma

N/A
Waitlist Available
Led By Jens Hillengass
Research Sponsored by Roswell Park Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up before and after strength training program up to 1 year
Awards & highlights

Study Summary

This trial studies the benefits of strength training for patients with multiple myeloma.

Eligible Conditions
  • Multiple Myeloma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~before and after strength training program up to 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and before and after strength training program up to 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility rate
Secondary outcome measures
Adherence rate (Cohort 1)
Adherence rate (Cohort 2)
Other outcome measures
"Immune fitness" frequencies and function of immune cell subsets
Clinical performance
Differences in lab parameters
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Cohort 1 (strength training)Experimental Treatment4 Interventions
Patients receive a Fitbit to track their physical activity, and complete an in-person personalized and supervised full-body strength training program over 1 hour BID up to 52 sessions for 6 months.
Group II: Cohort 2 (walking program)Active Control4 Interventions
Patients receive a Fitbit to track their physical activity, and complete an unsupervised walking program daily at home, increasing physical activity stepwise weekly, for 6 months.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
FitBit
2017
N/A
~480

Find a Location

Who is running the clinical trial?

Roswell Park Cancer InstituteLead Sponsor
402 Previous Clinical Trials
30,793 Total Patients Enrolled
20 Trials studying Multiple Myeloma
2,035 Patients Enrolled for Multiple Myeloma
Jens HillengassPrincipal InvestigatorRoswell Park Cancer Institute
3 Previous Clinical Trials
183 Total Patients Enrolled
3 Trials studying Multiple Myeloma
183 Patients Enrolled for Multiple Myeloma

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any current openings in this clinical trial for participants?

"Clinicaltrials.gov affirms that this study, which was initially advertised in December 2019 and updated last on September 2021 is not currently recruiting patients. However, 818 other medical trials are actively seeking volunteers at the moment."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Strength Training in Improving Pain and Quality of Life in Patients With Multiple Myeloma
2019. "Strength Training in Improving Pain and Quality of Life in Patients With Multiple Myeloma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03793907.
~12 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top